Rezolute, Inc.'s Shares Plummet After Clinical Trial Fiasco Raises Investor Concerns #United_States #Inc. #San_Francisco #RZLT #ersodetug #Rezolute
Significant Drop in Rezolute, Inc. Shares After Trial Failure and Investigations #United_States #San_Francisco #Hagens_Berman #ersodetug #Rezolute
Investors in Rezolute, Inc. Experience 90% Share Decline Amid Unsuccessful Drug Trial Results #USA #San_Francisco #Hagens_Berman #Rezolute_Inc #ersodetug
Rezolute, Inc. Shares Plummet 90% After Clinical Trial Failure Raises Concerns #United_States #San_Francisco #Rezolute_Inc #RZLT #ersodetug
To learn more about our sunRIZE Phase 3 preliminary demographic and baseline clinical characteristics, please check out our poster on our website: rezolutebio.com/wp-content/u... #SPES2025
#RZLT #CongenitalHI #raredisease #hyperinsulinism #ersodetug #PedSky #EndoSky #MedSky
Exciting day learning from families, clinicians about the latest in #congenitalhyperinsulinism and sharing updates about #ersodetug! Thank you #CHI and #ChildrensHospitalofPhiladelphia for an amazing day!
What a weekend for #Rezolute Medical Affairs! 🌍 Our team proudly represented at #ASPED2025 (Dubai), #SCOPE (Long Beach), and #AAP2025 (Denver)—sharing insights on congenital hyperinsulinism and ersodetug (RZ358). Grateful to all who engaged with us! #RZLT #ersodetug #EndoSky #RZLTMedAffairsInAction
Dive into the latest issue to reacquaint yourself with our Phase 2b (RIZE) study on congenital hyperinsulinism and see the science behind the visuals! (4/4) www.sciencedirect.com/science/arti...
#MedSky #PedSky #CongenitalHI #Ersodetug #Hyperinsulinism #Hypoglycemia #RareDisease
🎨 Cover Art Reveal: Unpacking the Science 🧬
Checkout Med’s journal cover this month, which illustrates Ersodetug as an insulin receptor modulating antibody (1/4)
#Med #Ersodetug #MOA #RareDisease #Hyperinsulinism #CongenitalHI #Hypoglycemia #ScientificArt #VisualStorytelling #MedSky